Reports
Sale
Global Glucose Monitoring Devices Market Size, Share, Report: By Product Type: Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices; By Applications; Type-1 Diabetes, Type-2 Diabetes; By Distribution Channel; Retail, Speciality Stores; By End User; Regional Analysis; Patent Analysis; Supplier Landscape; 2024-2032
Global Glucose Monitoring Devices Market Outlook
The global glucose monitoring devices market size was valued at USD 15.7 billion in 2023, driven by the increasing awareness about the importance of regular monitoring. The market size is anticipated to grow at a CAGR of 11.3% during the forecast period of 2024-2032 to achieve a value of USD 41.3 billion by 2032.
Glucose Monitoring Devices: Introduction
Diabetes is a serious and growing issue globally, where the inefficiency of the pancreas to produce insulin results in an increase in blood glucose levels. The sedentary lifestyle of the people is leading to increased cases of diabetes across the globe. The increasing prevalence of diabetes is a serious threat to the healthcare industry as it leads to various other health ailments, thus it is important to reduce or control the prevalence of this lifestyle disorders. The awareness about the importance of getting regular check-ups is rising with the rising awareness of the fatalities associated with diabetes.
Glucose monitoring devices offer convenience to the patients as these devices can be easily used at home to monitor the glucose levels. The convenience it offers to the patients is driving the glucose monitoring devices market growth. To check blood glucose levels, a blood sample is collected by poking a needle like device called lancet, provided in the glucose testing kit. Only a drop of blood is enough to measure blood sugar levels. After pricking the needle on the tip of the finger, the blood drop is dropped on a test strip and put it into the glucometer or glucose monitoring device. The device then shows the results on the screen. There are different sorts of glucose monitoring devices available in the market.
Global Glucose Monitoring Devices Market Analysis
The number of diabetic patients is rapidly increasing with the unhealthy lifestyles and food choices of the population and lack of active lifestyle, among other factors. The rising prevalence of diabetes among the population is primarily driving the glucose monitoring devices market growth.
Pharmaceutical companies are focusing on developing medications and devices, which would help diabetic patients monitor their glucose levels and recover much more effectively. The leading companies in the market are also collaborating to make more technologically advanced products, which is another factor that is contributing to the glucose monitoring devices market share. For instance, In February 2024, Ascensia Diabetes Care announced its global collaboration with SNAQ. SNAQ is an award-winning app that helps diabetic patients to know about their foods nutritional values and provide insights, such as counting carbs, protein, and fat content of meals just by uploading a photo and provide insights on what to eat in order to keeps glucose levels in targeted range.
Additionally, another collaboration was announced on June 24, 2024. The American Diabetes Association® (ADA) and Abbott announced their collaboration to make innovative product range for diabetic patients. Abbott and the ADA have been working together for more than 20 years to improve the quality of life of diabetics. Abbott has now decided to provide USD 2.65 million grants to the ADA over the next three years to enable them to collaborate with top healthcare professionals and key opinion leaders to understand the clinical evidence on the use of continuous glucose monitors (CGM) systems in developing personalized, and therapeutic nutrition.
Abbott and ADA also have plans to launch two pilot programs targeted at adults with Type 2 diabetes to gain a deeper understanding of the role that a CGM can play in personalized therapeutic nutrition.
Global Glucose Monitoring Devices Market Segmentations
Market Breakup by Product Type
- Self-Monitoring Blood Glucose Devices
- Glucose Strips
- Blood Glucose Metre
- Lancets
- Continuous Glucose Monitoring Devices
- Sensors
- Transmitters and Receiver
- Insulin Pumps
- Others
Market Breakup by Applications
- Type-1 Diabetes
- Type-2 Diabetes
Market Breakup by Distribution Channel
- Retail
- Speciality Stores
- Drug Stores/Pharmacies
- Online
- Others
Market Breakup by End User
- Hospitals
- Clinics
- Diagnostic Centres
- Home Healthcare
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Glucose Monitoring Devices Market Overview
The rising incidence of diabetes and the increasing geriatric population is contributing to the market growth as geriatric people are more prone to diabetes due to their age and weakened immune system. The increasing awareness regarding diabetes preventive care provided in healthcare facilities is aiding the rising glucose monitoring devices demand. The key players in the market are continuously focusing on launching new products to make life of their consumers a bit easier by developing advanced products that helps them on daily basis to improve the quality of their lifestyle. The increasing number of obese people globally is also directly contributing to the increase in diabetic patients as fat percentage in body is also responsible for the susceptibility to diabetes. The rising consumption of alcohol and smoking is also directly contributing to the rising number of diabetes patients worldwide, which is aiding the global glucose monitoring devices market growth.
Glucose Monitoring Devices Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott Laboratories
- Medtronic plc.
- F. Hoffmann-La Roche Ltd.
- Ascensia Diabetes Care
- Dexcom, Inc.
- Sanofi
- Novo Nordisk
- Insulet Corporation
- Ypsomed Holdings
- Glysens Incorporated
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Applications |
|
| Breakup by Distribution Channel |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Glucose Monitoring Devices Market Overview
3.1 Global Glucose Monitoring Devices Market Historical Value (2017-2023)
3.2 Global Glucose Monitoring Devices Market Forecast Value (2024-2032)
4 Global Glucose Monitoring Devices Market Landscape
4.1 Global Glucose Monitoring Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Glucose Monitoring Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Glucose Monitoring Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Glucose Monitoring Devices Market Segmentation
6.1 Global Glucose Monitoring Devices Market by Product Type
6.1.1 Self-Monitoring Blood Glucose Devices
6.1.1.1 Glucose Strips
6.1.1.2 Blood Glucose Metre
6.1.1.3 Lancets
6.1.2 Continuous Glucose Monitoring Devices
6.1.2.1 Sensors
6.1.2.2 Transmitters and Receiver
6.1.2.3 Insulin Pumps
6.1.2.4 Others
6.2 Global Glucose Monitoring Devices Market by Applications
6.2.1 Market Overview
6.2.2 Type-1 Diabetes
6.2.3 Type-2 Diabetes
6.3 Global Glucose Monitoring Devices Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Retail
6.3.3 Speciality Stores
6.3.4 Drug Stores/Pharmacies
6.3.5 Online
6.3.6 Others
6.4 Global Glucose Monitoring Devices Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinics
6.4.4 Diagnostic Centres
6.4.5 Home Healthcare
6.4.6 Others
6.5 Global Glucose Monitoring Devices Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Glucose Monitoring Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Glucose Monitoring Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Glucose Monitoring Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Glucose Monitoring Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Glucose Monitoring Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott Laboratories
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Medtronic plc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 F. Hoffmann-La Roche Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Ascensia Diabetes Care
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Dexcom, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Sanofi
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Novo Nordisk
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Insulet Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Ypsomed Holdings
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Glysens Incorporated
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
18 Global Glucose Monitoring Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 15.7 billion in 2023, driven by the rising number of diabetic patients worldwide.
The market is anticipated to grow at a CAGR of 11.3% during the forecast period of 2024-2032, likely to reach a market value of USD 41.3 billion by 2032.
The increasing awareness regarding diabetes preventive care and the rising incidence of diabetes are among the major factors driving the market growth.
Key players in the market collaborating to produce new and advanced products for diabetic patients, which is a key trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
Different glucose monitoring devices present in the market are self-monitoring blood glucose devices and continuous glucose monitoring devices.
They find wide applications in Type-1 Diabetes and Type-2 Diabetes.
The distribution channels involved are retail, speciality stores, drug stores/pharmacies, and online channels, among others.
The end users are hospitals, clinics, diagnostic centres, and home healthcare, among others.
Key players involved in the market are Abbott Laboratories, Medtronic plc., F. Hoffmann-La Roche Ltd., Ascensia Diabetes Care, Dexcom, Inc., Sanofi, Novo Nordisk, Insulet Corporation, Ypsomed Holdings, and Glysens Incorporated.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER